Carotid intima-media thickness in children with CKD: results from the CKiD study

Tammy M Brady1, Michael F Schneider, Joseph T Flynn

  • 1Department of Pediatrics, Division of Pediatric Nephrology, Johns Hopkins University, Baltimore, MD 21287, USA. tbrady8@jhmi.edu

Insights

Children with chronic kidney disease (CKD) have increased carotid intima-media thickness (cIMT), a marker of cardiovascular risk. Hypertension and dyslipidemia are significantly associated with this increased cIMT in pediatric CKD patients.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Health in Children
  • Biomedical Ultrasound

Background:

  • Increased carotid intima-media thickness (cIMT) predicts cardiovascular events in adults.
  • Children with chronic kidney disease (CKD) face elevated cardiovascular risk.
  • Identifying cardiovascular risk factors in pediatric CKD is crucial.

Purpose of the Study:

  • To identify cardiovascular risk factors associated with increased cIMT in children with CKD.
  • To compare cIMT in children with CKD to healthy controls.
  • To assess the impact of various factors on cIMT in pediatric CKD.

Main Methods:

  • Cross-sectional analysis of 101 children (aged 2-18) with mild to moderate CKD.
  • Comparison with 97 healthy pediatric controls.
  • cIMT measured using standardized B-mode ultrasound after 12 months of follow-up.

Main Results:

  • Children with CKD exhibited significantly higher median cIMT (0.43 mm) than healthy controls (0.41 mm).
  • Multivariable analysis revealed dyslipidemia and hypertension were associated with greater mean cIMT.
  • Factors like BMI, GFR, and birth weight were not significantly associated with cIMT.

Conclusions:

  • cIMT is significantly elevated in children with CKD, indicating heightened cardiovascular risk.
  • Hypertension and dyslipidemia are key risk factors associated with increased cIMT in this population.
  • Early identification and management of these risk factors are essential for pediatric CKD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...